Neil Stahl
2009
In 2009, Neil Stahl earned a total compensation of $2.9M as Senior Vice President, Research & Development Sciences at Regeneron Pharmaceuticals, a 160% increase compared to previous year.
Compensation breakdown
| Bonus | $1,081,088 |
|---|---|
| Option Awards | $1,382,430 |
| Salary | $390,400 |
| Other | $13,540 |
| Total | $2,867,458 |
Stahl received $1.4M in option awards, accounting for 48% of the total pay in 2009.
Stahl also received $1.1M in bonus, $390.4K in salary and $13.5K in other compensation.
Rankings
In 2009, Neil Stahl's compensation ranked 1,620th out of 9,885 executives tracked by ExecPay. In other words, Stahl earned more than 83.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,620 out of 9,885 | 84th |
Division Manufacturing | 574 out of 3,690 | 84th |
Major group Chemicals And Allied Products | 110 out of 866 | 87th |
Industry group Drugs | 72 out of 638 | 89th |
Industry Pharmaceutical Preparations | 58 out of 446 | 87th |
Source: SEC filing on April 26, 2010.
Stahl's colleagues
We found four more compensation records of executives who worked with Neil Stahl at Regeneron Pharmaceuticals in 2009.
2009
Leonard Schleifer
Regeneron Pharmaceuticals
Chief Executive Officer
2009
George Yancopoulos
Regeneron Pharmaceuticals
Chief Scientific Officer
2009
Murray Goldberg
Regeneron Pharmaceuticals
Chief Financial Officer
2009
Daniel Van Plew
Regeneron Pharmaceuticals